OBJECTIVE: Describe the epidemiology of healthcare-related (ie, healthcare-associated and hospital-acquired) pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) among hospitalized patients in community hospitals. DESIGN: Retrospective cohort study. SETTING: Twenty-four community hospitals in the southeastern United States affiliated with the Duke Infection Control Outreach Network (median size, 211 beds; range, 103-658 beds). METHODS: Adult patients with healthcare-related MRSA pneumonia admitted to study hospitals from January 1, 2008, to December 31, 2012, were identified using surveillance data. Seasonal and annual incidence rates (cases per 100,000 patient-days) were estimated using generalized estimating equation models. Characteristics of community-onset and hospital-onset cases were compared. RESULTS: A total of 1,048 cases of healthcare-related pneumonia due to MRSA were observed during 5,863,941 patient-days. The annual incidence rate of healthcare-related MRSA pneumonia increased from 11.3 cases per 100,000 patient-days (95% confidence interval [CI], 6.8-18.7) in 2008 to 15.5 cases per 100,000 patient-days (95% CI, 8.4-28.5) in 2012 (P = .055). The incidence rate was highest in winter months and lowest in summer months (15.4 vs 11.1 cases per 100,000 patient-days; incidence rate ratio, 1.39 [95% CI, 1.06-1.82]; P = .016). A total of 814 cases (77.7%) were community-onset healthcare-associated pneumonia cases; only 49 cases (4.7%) were ventilator-associated cases. Of 811 patients whose disposition was known, 240 (29.6%) died during hospitalization or were discharged to hospice. CONCLUSIONS: From 2008 through 2012, the incidence of healthcare-related MRSA pneumonia among patients who were admitted to a large network of community hospitals increased, despite the decreasing incidence of invasive MRSA infections nationwide. Additional study is warranted to evaluate trends in this important and potentially modifiable public health problem.
OBJECTIVE: Describe the epidemiology of healthcare-related (ie, healthcare-associated and hospital-acquired) pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) among hospitalized patients in community hospitals. DESIGN: Retrospective cohort study. SETTING: Twenty-four community hospitals in the southeastern United States affiliated with the Duke Infection Control Outreach Network (median size, 211 beds; range, 103-658 beds). METHODS: Adult patients with healthcare-related MRSA pneumonia admitted to study hospitals from January 1, 2008, to December 31, 2012, were identified using surveillance data. Seasonal and annual incidence rates (cases per 100,000 patient-days) were estimated using generalized estimating equation models. Characteristics of community-onset and hospital-onset cases were compared. RESULTS: A total of 1,048 cases of healthcare-related pneumonia due to MRSA were observed during 5,863,941 patient-days. The annual incidence rate of healthcare-related MRSA pneumonia increased from 11.3 cases per 100,000 patient-days (95% confidence interval [CI], 6.8-18.7) in 2008 to 15.5 cases per 100,000 patient-days (95% CI, 8.4-28.5) in 2012 (P = .055). The incidence rate was highest in winter months and lowest in summer months (15.4 vs 11.1 cases per 100,000 patient-days; incidence rate ratio, 1.39 [95% CI, 1.06-1.82]; P = .016). A total of 814 cases (77.7%) were community-onset healthcare-associated pneumonia cases; only 49 cases (4.7%) were ventilator-associated cases. Of 811 patients whose disposition was known, 240 (29.6%) died during hospitalization or were discharged to hospice. CONCLUSIONS: From 2008 through 2012, the incidence of healthcare-related MRSA pneumonia among patients who were admitted to a large network of community hospitals increased, despite the decreasing incidence of invasive MRSA infections nationwide. Additional study is warranted to evaluate trends in this important and potentially modifiable public health problem.
Authors: Raymund Dantes; Yi Mu; Ruth Belflower; Deborah Aragon; Ghinwa Dumyati; Lee H Harrison; Fernanda C Lessa; Ruth Lynfield; Joelle Nadle; Susan Petit; Susan M Ray; William Schaffner; John Townes; Scott Fridkin Journal: JAMA Intern Med Date: 2013-11-25 Impact factor: 21.873
Authors: Nidhu Baby; Andrew C Faust; Terri Smith; Lyndsay A Sheperd; Laura Knoll; Edward L Goodman Journal: Antimicrob Agents Chemother Date: 2017-03-24 Impact factor: 5.191
Authors: David B Huang; Ian Morrissey; Timothy Murphy; Stephen Hawser; Mark H Wilcox Journal: Eur J Clin Microbiol Infect Dis Date: 2017-12-08 Impact factor: 3.267
Authors: Ana López-de-Andrés; Javier de Miguel-Díez; Isabel Jiménez-Trujillo; Valentín Hernández-Barrera; José M de Miguel-Yanes; Manuel Méndez-Bailón; Napoleón Pérez-Farinós; Miguel Á Ngel Salinero-Fort; Rodrigo Jiménez-García Journal: BMJ Open Date: 2017-01-05 Impact factor: 2.692
Authors: Aderonke Odutola; Christian Bottomley; Syed A Zaman; Jodi Lindsay; Muhammed Shah; Ilias Hossain; Malick Ndiaye; Chidebere D I Osuorah; Yekini Olatunji; Henry Badji; Usman N A Ikumapayi; Ahmad Manjang; Rasheed Salaudeen; Lamin Ceesay; Momodou Jasseh; Richard A Adegbola; Tumani Corrah; Philip C Hill; Brian M Greenwood; Grant A Mackenzie Journal: Emerg Infect Dis Date: 2019-04 Impact factor: 6.883
Authors: Michael J Durkin; S Reza Jafarzadeh; Kevin Hsueh; Ya Haddy Sallah; Kiraat D Munshi; Rochelle R Henderson; Victoria J Fraser Journal: Infect Control Hosp Epidemiol Date: 2018-02-27 Impact factor: 3.254